Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07216885 · ClinicalTrials.gov registry record · NA

Solv Multi-Pass Hemodialysis System In-Center Clinical Study

A NA study of End Stage Renal Disease, sponsored by Medtronic - MITG.

Recruiting
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT07216885 is a NA study of End Stage Renal Disease that is actively recruiting participants, run by Medtronic - MITG. The registered enrollment target is 46 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07216885, a NA study of End Stage Renal Disease, is actively recruiting participants, sponsored by Medtronic - MITG.

RECRUITING
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and patients currently receiving HD in an in-center environment. All vascular access types including AV-fistula, AV-graft, and tunneled hemodialysis catheters.

Conditions Studied

End Stage Renal Disease

Interventions

  • DEVICE Solv Multi-Pass Hemodialysis System

Study Locations (1)

South Carolina

  • Carolina Nephrology - Greenville

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2026-01-13
Est. Completion 2026-07
Phase NA

Sponsor

Medtronic - MITG

119 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07216885

The ClinicalTrials.gov registry entry for NCT07216885 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (94% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which Solv Multi-Pass Hemodialysis System is the first listed.

NCT07216885 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT07216885 about?

NCT07216885 is a clinical study titled "Solv Multi-Pass Hemodialysis System In-Center Clinical Study". Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and ...

What is the current status of trial NCT07216885?

This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2026-01-13. Estimated completion is 2026-07.

What conditions does trial NCT07216885 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT07216885?

The interventions under investigation include: Solv Multi-Pass Hemodialysis System (DEVICE).

Who is sponsoring clinical trial NCT07216885?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07216885 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

South Carolina

All trials with a study site in South Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.